Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rapid Diagnostic Technology for Acute Upper Gastrointestinal Bleeding Based on Analysis of Volatile Organic Compounds (VOCs) in Exhaled Breath

NCT06877507 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT06877507
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877507 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rapid Diagnostic Technology for Acute Upper Gastrointestinal Bleeding Based on Analysis of Volatile Organic Compounds (VOCs) in Exhaled Breath
Lead sponsor
Beijing 302 Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
March 20, 2025
Completion date
July 20, 2025
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal hemorrhage, volatile organic compound